Metabolites of arachidonic acid (AA) and other polyunsaturated fatty acids (PUFAs) comprise a large and structurally diverse family of endogenous autacoids, second messengers, and regulators that maintain homeostasis, modulate physiologic responses, and contribute to pathologic conditions. Known collectively as eicosanoids, the primary metabolites are subject to a further cascade of enzymatic and non- enzymatic transformations resulting in a host of secondary metabolites that together constitute the "arachidonate cascade". Recent studies from this and other laboratories have revealed a variety of new, bioactive additions to the cascade, especially from the recently discovered cytochrome P450 branch. It has been the long-term objective of this laboratory to (a) develop new chemical, biochemical, and pharmacological tools;and (b) to exploit these tools to elucidate the biogenesis, structure/stereochemistry, physiologic role(s), regulation, site of action and mechanism of these novel eicosanoids. During the next budget cycle, these long-term objectives will be broadly pursued, but three key areas will be emphasized and systematically investigated: 1. Synthetic Methodology/Total Syntheses (a) Asymmetric synthesis of 1-hydroxystannanes (b) Cross-coupling of protected 1-hydroxystannanes with sp2-halides (c) Ir-catalyzed C-H functionalization of olefins (d) Selective ester reductions using manganese catalysts (e) Asymmetric Payne epoxidation: Stereocontrolled synthesis of hydroxylated EETs 2. PUFA Metabolite Agonists and Antagonists (a) Prepare PUFA metabolite analogs with agonist or antagonist activity (b) Optimize and evaluate analogs for in vitro and in vivo activity in collaborative pharmacological/physiological studies 3. Characterization, Isolation and Identification of CYP PUFA Metabolite Receptors and Other Regulatory Macromolecules (a) EET receptor (b) 17,18-Epoxy-EPA receptor (c) 20-HETE receptor

Public Health Relevance

polyunsaturated fatty acids are obtained from our diets and transformed into a large family of metabolites that help maintain homeostasis, modulate physiologic responses, and contribute to pathologic conditions. It is the long-term objective of this laboratory to identify these metabolites, develop biochemical and chemical tools to better understand their physiologic roles, and ultimately intervene pharmacologically.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM031278-28
Application #
8302421
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Okita, Richard T
Project Start
1983-12-01
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2014-07-31
Support Year
28
Fiscal Year
2012
Total Cost
$403,524
Indirect Cost
$146,503
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Garcia, Victor; Shkolnik, Brian; Milhau, Laura et al. (2016) 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding. J Pharmacol Exp Ther 356:525-33
Sato, Yuka; Sato, Waichi; Maruyama, Shoichi et al. (2015) Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids. J Am Soc Nephrol 26:1806-15
Garcia, Victor; Cheng, Jennifer; Weidenhammer, Adam et al. (2015) Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS. Prostaglandins Other Lipid Mediat 116-117:124-30
Jat, Jawahar L; Paudyal, Mahesh P; Gao, Hongyin et al. (2014) Direct stereospecific synthesis of unprotected N-H and N-Me aziridines from olefins. Science 343:61-5
Wang, Rui; Falck, John R (2014) Transition Metals Catalyzed Element-Cyano Bonds Activations. Catal Rev Sci Eng 56:288-331
Hye Khan, Md Abdul; Pavlov, Tengis S; Christain, Sarah V et al. (2014) Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition. Clin Sci (Lond) 127:463-74
Khan, Abdul Hye; Falck, John R; Manthati, Vijaya L et al. (2014) Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. Front Pharmacol 5:216
Ding, Yindi; Frömel, Timo; Popp, Rüdiger et al. (2014) The biological actions of 11,12-epoxyeicosatrienoic acid in endothelial cells are specific to the R/S-enantiomer and require the G(s) protein. J Pharmacol Exp Ther 350:14-21
Nithipatikom, Kasem; Endsley, Michael P; Pfeiffer, Adam W et al. (2014) A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol. J Lipid Res 55:2093-102
Sari, A Nihal; Korkmaz, Belma; Serin, Mehmet Sami et al. (2014) Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKKβ/IκB-α/NF-κB pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock. Inflamm Res 63:741-56

Showing the most recent 10 out of 361 publications